Investigating the utility of clinical outcomeguided mutual information network in networkbased Cox regression

BMC Systems Biology

Volumn 9, Issue , 2015, Pages

  Jeong, Hyun hwan ^a   Kim, So Yeon ^a   Wee, Kyubum ^a   Sohn, Kyung Ah ^a  

^a Ajou University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; CYSTADENOCARCINOMA; FEMALE; GENE REGULATORY NETWORK; GENETICS; HUMAN; OVARY TUMOR; PROCEDURES; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; SURVIVAL;

COMPUTATIONAL BIOLOGY; CYSTADENOCARCINOMA, SEROUS; FEMALE; GENE REGULATORY NETWORKS; HUMANS; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 84928736284     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-9-S1-S8     Document Type: Article

References (36)

1. Cox D: Regression Models and Life-Tables. In Breakthroughs in Statistics. Springer New York;Kotz S, Johnson N 1992:527-541.
2. Tibshirani R: The lasso method for variable selection in the Cox model. Statistics in medicine 1997, 16(4):385-395.
3. Li H, Luan Y: Kernel Cox regression models for linking gene expression profiles to censored survival data. Pacific Symposium on Biocomputing 2002, 65.
4. Gui J, Li H: Penalized Cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data. Bioinformatics 2005, 21(13):3001-3008.
5. Li C, Li H: Network-constrained regularization and variable selection for analysis of genomic data. Bioinformatics 2008, 24(9):1175-1182.
6. Kim S, Sohn K-A, Xing EP: A multivariate regression approach to association analysis of a quantitative trait network. Bioinformatics 2009, 25(12):i204-i212.
7. Cheng W, Zhang X, Guo Z, Shi Y, Wang W: Graph-regularized dual Lasso for robust eQTL mapping. Bioinformatics 2014, 30(12):i139-i148.
8. Lee S, Xing EP: Leveraging input and output structures for joint mapping of epistatic and marginal eQTLs. Bioinformatics 2012, 28(12):i137-i146.
9. Zhang W, Ota T, Shridhar V, Chien J, Wu B, Kuang R: Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment. PLoS computational biology 2013, 9(3): e1002975.
10. Steuer R, Kurths J, Daub CO, Weise J, Selbig J: The mutual information: detecting and evaluating dependencies between variables. Bioinformatics (Oxford, England) 2002, 18(Suppl 2):S231-240.
11. Goebel B, Dawy Z, Hagenauer J, Mueller JC: An approximation to the distribution of finite sample size mutual information estimates. IEEE International Conference on Communications, 2005 ICC 2005, 2:1102-1106.
12. Leem S, Jeong H-H, Lee J, Wee K, Sohn K-A: Fast detection of high-order epistatic interactions in genome-wide association studies using information theoretic measure. Computational Biology and Chemistry 2014.
13. Hu T, Sinnott-Armstrong Na, Kiralis JW, Andrew AS, Karagas MR, Moore JH: Characterizing genetic interactions in human disease association studies using statistical epistasis networks. BMC bioinformatics 2011, 12:364.
14. Butte AJ, Kohane IS: Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing 2000, 426:418-429.
15. Heagerty PJ, Lumley T, Pepe MS: Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000, 56(2):337-344.
16. Li H, Gui J: Partial Cox regression analysis for high-dimensional microarray gene expression data. Bioinformatics 2004, 20(Suppl 1): i208-215.
17. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer chemotherapy reports Part 1 1966, 50(3):163-170.
18. Chen J, Bardes EE, Aronow BJ, Jegga AG: ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 2009, 37 Web Server: W305-311.
19. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature genetics 2000, 25:25-29.
20. Davis AP, Murphy CG, Johnson R, Lay JM, Lennon-Hopkins K, Saraceni-Richards C, Sciaky D, King BL, Rosenstein MC, Wiegers TC, et al: The Comparative Toxicogenomics Database: update 2013. Nucleic Acids Res 2013, 41 Database: D1104-1114.
21. Benjamini Y: Discovering the false discovery rate. Journal of the Royal Statistical Society: Series B (Statistical Methodology) 2010, 72(4):405-416.
22. Theurillat JP, Metzler SC, Henzi N, Djouder N, Helbling M, Zimmermann AK, Jacob F, Soltermann A, CaduffR, Heinzelmann-Schwarz V, et al: URI is an oncogene amplified in ovarian cancer cells and is required for their survival. Cancer Cell 2011, 19(3):317-332.
23. Gao J, Yang X, Yin P, Hu W, Liao H, Miao Z, Pan C, Li N: The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer. International journal of oncology 2012, 40(4):1203-1209.
24. Maines-Bandiera S, Woo MM, Borugian M, Molday LL, Hii T, Gilks B, Leung PC, Molday RS, Auersperg N: Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer. Int J Gynecol Cancer 2010, 20(1):16-22.
25. Clauss A, Ng V, Liu J, Piao H, Russo M, Vena N, Sheng Q, Hirsch MS, Bonome T, Matulonis U, et al: Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival. Neoplasia 2010, 12(2):161-172.
26. Liu Y, Devescovi V, Chen S, Nardini C: Multilevel omic data integration in cancer cell lines: advanced annotation and emergent properties. BMC Systems Biology 2013, 7(1):14.
27. Kzhyshkowska J, Gratchev A, Goerdt S: Human chitinases and chitinaselike proteins as indicators for inflammation and cancer. Biomarker insights 2007, 2:128.
28. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Research 2003, 13:2498-2504.
29. Zhang B, Horvath S: A general framework for weighted gene coexpression network analysis. Statistical applications in genetics and molecular biology 2005, 4:Article17.
30. Jeong H, Tombor B, Albert R, Oltvai ZN, BarabásiaL: The large-scale organization of metabolic networks. Nature 2000, 407:651-654.
31. Diez D, Wheelock AM, Goto S, Haeggström JZ, Paulsson-Berne G, Hansson GK, Hedin U, Gabrielsen A, Wheelock CE: The use of network analyses for elucidating mechanisms in cardiovascular disease. Molecular bioSystems 2010, 6:289-304.
32. Carter SL, Brechbühler CM, Griffin M, Bond AT: Gene co-expression network topology provides a framework for molecular characterization of cellular state. Bioinformatics (Oxford, England) 2004, 20:2242-2250.
33. Reguly T, Breitkreutz A, Boucher L, Breitkreutz B-J, Hon GC, Myers CL, Parsons A, Friesen H, Oughtred R, Tong A, et al: Comprehensive curation and analysis of global interaction networks in Saccharomyces cerevisiae. Journal of biology 2006, 5:11.
34. Engeland A, Tretli S, Bjørge T: Height, Body Mass Index, and Ovarian Cancer: A Follow-Up of 1.1 Million Norwegian Women. Journal of the National Cancer Institute 2003, 95(16):1244-1248.
35. Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A: Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Experimental diabetes research 2012, 2012:789174.
36. Parazzini F, Moroni S, La Vecchia C, Negri E, dal Pino D, Bolis G: Ovarian cancer risk and history of selected medical conditions linked with female hormones. European journal of cancer 1997, 33(10):1634-1637.